Fusion Pharmaceuticals Inc. - Common Shares (NQ:FUSN)

21.55 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jun 3, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Fusion Pharmaceuticals Inc. - Common Shares

< Previous 1 2 3 4 Next >

FUSN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Fusion Pharmaceuticals Inc. Is Fair to Shareholders

March 19, 2024

From Halper Sadeh LLC

Via Business Wire

AstraZeneca's $2.4B Fusion Pharmaceuticals' Acquisition Signals Shift In Efforts From Traditional Regimens For More Targeted Cancer Treatments ↗

March 19, 2024

AstraZeneca to acquire Fusion Pharmaceuticals for $21.00 per share cash plus $3.00 per share CVR upon regulatory milestone achievement, marking a significant $2.4 billion deal. Enhancing cancer...

Via Benzinga

A Glimpse Into The Expert Outlook On Fusion Pharmaceuticals Through 7 Analysts ↗

March 04, 2024

Via Benzinga

7 Low-Cost Call Options With High-Profit Potential ↗

February 19, 2024

Call options are exciting but they can be a bit confusing. Let me guide you to compelling opportunities among certain hot names.

Via InvestorPlace

Expert Outlook: Fusion Pharmaceuticals Through The Eyes Of 6 Analysts ↗

January 26, 2024

Via Benzinga

A Closer Look at 4 Analyst Recommendations For Fusion Pharmaceuticals ↗

December 27, 2023

Via Benzinga

Recap: Fusion Pharmaceuticals Q1 Earnings ↗

May 11, 2023

Via Benzinga

Fusion Pharmaceuticals Earnings Perspective: Return On Capital Employed ↗

March 20, 2023

Via Benzinga

Fusion Pharmaceuticals - Already Discovered By Wall Street ↗

February 06, 2024

Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines in Canada and the United States.

Via Talk Markets

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 19, 2024

Via Benzinga

Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket ↗

January 05, 2024

Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of...

Via Benzinga

Topics Intellectual Property

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

January 05, 2024

Pre-market stock movers are worth checking on Friday as we lay out all of the biggest stories worth keeping tabs on this morning!

Via InvestorPlace

Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday ↗

January 02, 2024

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.

Via Benzinga

Topics Stocks

Recent M&A Bodes Well For Targeted Cancer Therapy Player Fusion Pharmaceuticals, Analyst Say AstraZeneca Is Favorably Positioned ↗

December 27, 2023

With recent merger and acquisition deals in the targeted radiopharmaceutical therapy (TRT) space, on Tuesday, Oppenheimer noted that Fusion Pharmaceuticals Inc (NASDAQ: FUSN) is potentially the sole...

Via Benzinga

Meta To Rally Over 18%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

December 27, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

December 26, 2023

Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth...

Via Benzinga

Fusion's Pharma's Targeted Cancer Therapy Potential Gets This Analyst Bullish, Sees 100% Upside ↗

December 20, 2023

RBC Capital Markets initiated coverage on Fusion Pharmaceuticals Inc (NASDAQ: FUSN), saying the radiopharmaceutical industry is a burgeoning area in therapeutics following the green light for Novartis...

Via Benzinga

Agilent Posts Upbeat Results, Joins Burlington Stores, Hibbett And Other Big Stocks Moving Higher On Tuesday ↗

November 21, 2023

U.S. stocks traded lower, with the Dow Jones falling around 90 points on Tuesday.

Via Benzinga

Topics Stocks

BWXT Medical Expands Collaboration with Fusion Pharmaceuticals Through Strengthened Actinium Supply and Access to Generator Technology

November 16, 2023

From BWX Technologies, Inc.

Via Business Wire

Fusion Pharmaceuticals Poised For Leadership In Targeted Cancer Therapies: Oppenheimer ↗

September 29, 2023

Oppenheimer initiated coverage on Fusion Pharmaceuticals Inc (NASDAQ: FUSN), citing the company's pipeline as among the best in the space with alpha-emitter-based targeted radionuclide therapies...

Via Benzinga

Fusion Pharmaceuticals is Future Pillar of Cancer Treatment: Analyst ↗

June 23, 2023

Raymond James has initiated coverage on Fusion Pharmaceuticals Inc (NASDAQ: FUSN) with an Outperform rating and a

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2023 ↗

June 23, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023 ↗

September 29, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

June 21, 2023

Via Benzinga

Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 14, 2023

Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 14, 2023

Via Benzinga

Avis Budget, Zoetis, Palantir Technologies And Other Big Stocks Moving Higher On Tuesday ↗

February 14, 2023

U.S. stocks traded higher, with the Dow Jones gaining over 50 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Dow Falls 150 Points; US Consumer Prices Rise 0.5% In January ↗

February 14, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.46% to 34,089.44 while the NASDAQ fell 0.42%...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 14, 2023

Via Benzinga

Fusion Pharma Raises $60M To Fund Acquisition Of Prostate Cancer-Targeted Radiopharmaceutical ↗

February 14, 2023

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.